Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-31

Clinical Trial Update: Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study. [NA]

View source ↗

Summary

A prospective study evaluating imaging techniques and biological markers to predict and identify pseudoprogression in glioblastoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Glioblastoma | NA | Status: RECRUITING